BRIEF-Starpharma Holdings Says Viraleze To Be Launched In The UK
- ByReuters-
March 25 (Reuters) - Starpharma Holdings Ltd SPL.AX : * VIRALEZE TO BE LAUNCHED WITH LLOYDSPHARMACY IN THE UK
March 25 (Reuters) - Starpharma Holdings Ltd SPL.AX : * VIRALEZE TO BE LAUNCHED WITH LLOYDSPHARMACY IN THE UK
Feb 25 (Reuters) - Starpharma Holdings Ltd SPL.AX : * REPORTED LOSS FOR HALF-YEAR OF $10.4M
Feb 23 (Reuters) - Starpharma Holdings Ltd SPL.AX : * STARPHARMA HOLDINGS LTD - VIRALEZE ANTIVIRAL NASAL SPRAY REGISTERED IN EUROPE
EU attempting to revive Iran nuclear deal with market staying pessimistic Crude prices could rebound from oversold conditions but stay off 2022 highs Both Iran, US likely looking...
Starpharma Holdings Limited, a biopharmaceutical company, engages in the research, development, and commercialization of dendrimer products for pharmaceutical, life-science, and other applications worldwide. It offers VivaGel, a non-antibiotic therapy for the treatment and prevention of bacterial vaginosis. The company also develops VivaGel condom, an antiviral condom; and VIRALEZE, an antiviral nasal spray. In addition, it develops DEP, a dendrimer drug delivery technology, including DEP docetaxel that is in Phase 2 clinical trials, DEP cabazitaxel that is in Phase 2 clinical trial, DEP gemcitabine that is in a Phase 1/2 clinical trials, and DEP irinotecan that is in Phase 2 clinical trials for the treatment of cancer; DEP radiotheranostics for cancer treatment and diagnosis; DEP Antibody Drug Conjugates; DEP HER-2 ADC; DEP non-oncology candidates; and DEP AZD0466, which is in Phase 1/2 clinical trials to treat haematological malignancies. The company was founded in 1996 and is headquartered in Abbotsford, Australia.
| Average | 95.000 (+18527.45% Upside) |
| High | 95 |
| Low | 95 |
| Price | 0.51 |
| No. of Analysts | 1 |
Type | 5 Min | 15 Min | Hourly | Daily | Monthly |
|---|---|---|---|---|---|
| Moving Averages | Neutral | Strong Sell | Strong Sell | Strong Sell | Strong Sell |
| Technical Indicators | Sell | Strong Sell | Strong Sell | Strong Sell | Strong Sell |
| Summary | Neutral | Strong Sell | Strong Sell | Strong Sell | Strong Sell |
Name | Last | High | Low | Chg. | Chg. % | Vol. | Time | ||
|---|---|---|---|---|---|---|---|---|---|
| 4.00 | 4.01 | 3.95 | +0.060 | +1.52% | 11.23M | Sydney | |||
| 0.094 | 0.095 | 0.093 | +0.002 | +2.17% | 2.10M | Sydney | |||
| 6.06 | 6.21 | 6.05 | -0.13 | -2.10% | 6.93M | Sydney | |||
| 3.03 | 3.04 | 3.01 | 0.00 | 0.00% | 501.41K | Sydney | |||
| 1.65 | 1.69 | 1.54 | +0.090 | +5.77% | 1.34M | Sydney | |||
| 0.013 | 0.013 | 0.013 | 0.00 | 0.00% | 0.00 | Sydney | |||
| 0.025 | 0.025 | 0.024 | +0.001 | +4.17% | 1.35M | Sydney | |||
| 0.185 | 0.195 | 0.185 | -0.010 | -5.13% | 7.16M | Sydney | |||
| 13.43 | 13.73 | 13.41 | -0.14 | -1.03% | 409.15K | Sydney | |||
| 299.72 | 301.42 | 299.08 | +0.72 | +0.24% | 430.41K | Sydney | |||
| 2.59 | 2.605 | 2.59 | 0.00 | 0.00% | 0.00 | Sydney | |||
| 0.037 | 0.039 | 0.036 | 0.00 | 0.00% | 0.00 | Sydney | |||
| 7.03 | 7.04 | 6.96 | +0.03 | +0.43% | 977.24K | Sydney | |||
| 0.11 | 0.115 | 0.11 | -0.005 | -4.35% | 25.04K | Sydney | |||
| 0.675 | 0.71 | 0.675 | -0.035 | -4.93% | 3.10M | Sydney |